Glaxo's Lotronex Risk-Management Program Emphasizes Appropriate Use

Glaxo Wellcome is proposing an "appropriate use" campaign as the focus of its risk-management plan for Lotronex, the company told FDA's Gastrointestinal Drugs Advisory Committee June 27.

Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

More from Archive

More from Pink Sheet